跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe
Approved
STANDARD
ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe
Accord Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6db347323f007d3a
Company
Accord Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
6db347323f007d3a
Product Name
ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe
Artg Id
338223
Artg Name
ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe
Sponsor
Accord Healthcare Pty Ltd
Company Detail Path
/organization/accord-healthcare-pty-ltd
Artg Date
2020-11-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6db347323f007d3a
Type
Standard
Back to TGA Approvals